David Hering serves as Executive at Adagio Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, David Hering has executed 1 insider transactions totaling $36.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 1, 2022 involved purchasing 8,000 shares valued at $36.2K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 1, 2022 | ADGI | $36.2K | Purchase | 8,000 | $4.52 | Discretionary |
David Hering currently holds 8,000 shares of Adagio Therapeutics, Inc. (ADGI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Hering has been a net buyer of ADGI stock. They have purchased $36.2K and sold $0 worth of shares.
David Hering's most recent insider trade was on Sep 1, 2022, when they purchased 8,000 shares at $4.52 per share.
Get notified when new Form 4 filings are submitted